医療用マリファナのドイツ市場2020-2027:製品別(花、油)、用途別(慢性疼痛、精神障害、癌)、地域別

◆英語タイトル:Germany And Netherlands Medical Marijuana Market Size, Share & Trends Analysis Report By Product (Flower, Oil), By Application (Chronic Pain, Mental Disorder, Cancer), By Country, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20NV166
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年9月7日
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:ドイツ・オランダ
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥678,300見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥792,300見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,020,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、医療用マリファナのドイツ市場について調査・分析し、調査目的、エグゼクティブサマリー、市場要因・動向・範囲、用途別市場規模、製品別市場規模、地域別市場規模、競争分析、企業概要などの項目を掲載しています。
【レポートの概要】

Germany And Netherlands Medical Marijuana Market Growth & Trends
The Germany and Netherlands medical marijuana market size is expected to reach USD 2.9 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 13.0% over the forecast period. The growing adoption of marijuana for the treatment of chronic diseases is positively impacting the growth. Furthermore, increasing its legalization and use for therapeutic purposes is further bolstering revenue growth over the forecast period.

Based on the product, the flower segment dominated the market in 2019. Flowers are generally utilized for smoking purposes and have applications in a variety of health-related conditions such as in the treatment of glaucoma and nausea. Such factors are contributing to the increase in demand for the flower. In addition, rapid onset of action with respect to the smoking of flowers and its applications in alleviating chronic pain, reducing cancer, stopping the progression of Alzheimer’s disease is further propelling the market growth.

In 2019, the chronic pain segment accounted for the highest revenue share. This growth is attributed to the presence of legal programs in both the countries and its increasing acceptance for various chronic conditions. In addition, scientific literature supporting its benefits in the treatment of various diseases, including chronic pain is further fueling the growth.

Germany dominated the market with a revenue share of 98.0% in 2019 owing to the increasing population and high demand for medical use. Furthermore, liberal government regulations, sanctioning of cultivation licenses in the country, and its legalization for health-related or therapeutic purposes are boosting the growth of the market in the country.

Germany And Netherlands Medical Marijuana Market Report Highlights

• Increasing adoption of marijuana for the treatment of chronic diseases and its legalization to be used for therapeutic purposes is driving the market

• The flower segment dominated the market in 2019, owing to the rising number of applications in a variety of health-related conditions such as treatment of glaucoma and nausea.

• The chronic pain segment dominated the market in 2019, owing to the presence of legal programs in both the countries and increasing acceptance of medical marijuana to treat various chronic conditions.

• Germany dominated the market with a revenue share of 98.0% in 2019, owing to the increasing population of the country and high demand for medical use.

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Segment Share Calculation
1.5 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Germany & Netherlands Medical Marijuana Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Germany & Netherlands Medical Marijuana Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Growing adoption of medical marijuana for treatment of chronic diseases
3.2.1.2 Increasing preference towards cannabis extracts such as oils and tinctures
3.2.1.3 Impending legalization of marijuana for recreational/adult use
3.2.2 Market Restraint Analysis
3.2.2.1 Legalization of medical marijuana only for selected indications
3.2.2.2 Supply shortage of medical marijuana in various countries
3.2.3 Penetration & Growth Prospects Mapping
3.2.4 Germany & Netherlands Medical Marijuana Market – Pestle Analysis
3.2.5 Germany & Netherlands Medical Marijuana Market: Porter’s Analysis
Chapter 4 Germany & Netherlands Medical Marijuana Market: Application Estimates &Trend Analysis
4.1 Marijuana Market: Application Movement Analysis
4.2 Chronic Pain
4.2.1 Chronic Pain Market Estimates And Forecasts, 2014 – 2027 (USD Million)
4.3 Mental Disorders
4.3.1 Mental Disorders Market Estimates And Forecasts, 2014 – 2027 (USD Million)
4.4 Cancer
4.4.1 Cancer Market Estimates And Forecasts, 2014 – 2027 (USD Million)
4.5 Others
4.5.1 Others Market Estimates And Forecasts, 2014 – 2027 (USD Million)
Chapter 5 Germany & Netherlands Medical Marijuana Market: Product Type Estimates & Trend Analysis
5.1 Germany & Netherlands Medical Marijuana Market: Product Type Movement Analysis
5.2 Flower
5.2.1 Flower Market Estimates And Forecasts, 2014 – 2027 (USD Million)
5.3 Oil
5.3.1 Oil Market Estimates And Forecasts, 2014 – 2027 (USD Million
Chapter 6 Germany & Netherlands Medical Marijuana Market: Country Estimates & Trend Analysis
6.1 Germany & Netherlands Medical Marijuana Market Share, By Country, 2019 & 2027
6.2 Germany
6.2.1 Germany Medical Marijuana Market Estimates And Forecasts, 2014 – 2027 (USD Million)
6.3 Netherlands
6.3.1 Netherlands Medical Marijuana Market Estimates And Forecasts, 2014 – 2027 (USD Million)
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
7.3 Vendor Landscape
7.3.1 Competitive Dashboard & Company Market Position Analysis
7.3.2 Synergy Analysis: Major Deals & Strategic Alliances
7.3.3 List Of Key Emerging Companies /TechnologyDisruptors/Innovators
Chapter 8 Competitive Landscape
8.1 ADREXpharma GmbH
8.1.1 Company Overview
8.1.2 Strategic Initiatives
8.2 Canopy Growth Corporation
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Strategic Initiatives
8.3 Aphria, Inc.
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Strategic Initiatives
8.4 Aurora Cannabis
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Strategic Initiatives
8.5 Tilray
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Strategic Initiatives
8.6 GW Pharmaceuticals, plc
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Strategic Initiatives
8.7 Organigram Holdings, Inc.
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Strategic Initiatives
8.8 The Cronos Group
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Strategic Initiatives
8.9 Demecan GmbH
8.9.1 Company Overview
8.9.2 Strategic Initiatives
8.10 Cannamedical Pharma GmbH
8.10.1 Company Overview
8.10.2 Strategic Initiatives

List of Tables

Table 1 Partial list of secondary sources
Table 2 Germany medical marijuana market estimates and forecasts, by product, 2014 - 2027 (USD Million)
Table 3 Germany medical marijuana market estimates and forecasts, by application, 2014 - 2027 (USD Million)
Table 4 Netherlands medical marijuana market estimates and forecasts, by product, 2014 - 2027 (USD Million)
Table 5 Netherlands medical marijuana market estimates and forecasts, by application, 2014 - 2027 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Germany & Netherlands medical marijuana market snapshot, 2019 (USD Million)
Fig. 9 Germany & Netherlands medical marijuana market segmentation
Fig. 10 Germany & Netherlands medical marijuana market dynamics
Fig. 11 Germany & Netherlands medical marijuana market driver impact
Fig. 12 Germany & Netherlands medical marijuana market restraints impact
Fig. 13 Penetration & growth prospects mapping for Germany & Netherlands medical marijuana market
Fig. 14 Germany & Netherlands medical marijuana market - PESTLE analysis
Fig. 15 Germany & Netherlands medical marijuana market - Porter’s Analysis
Fig. 16 Chronic pain market estimates and forecasts, 2014 - 2027 (USD Million)
Fig. 17 Mental Disorders market estimates and forecasts, 2014 - 2027 (USD Million)
Fig. 18 Cancer market estimates and forecasts, 2014 - 2027 (USD Million)
Fig. 19 Others market estimates and forecasts, 2014 - 2027 (USD Million)
Fig. 20 Germany & Netherlands medical marijuana market, product outlook: Key takeaways
Fig. 21 Germany & Netherlands medical marijuana market: Product movement analysis (2019 & 2027) (USD Million)
Fig. 22 Flower market estimates and forecasts, 2014 - 2027 (USD Million)
Fig. 23 Oil market estimates and forecasts, 2014 - 2027 (USD Million)
Fig. 24 Country marketplace: Key takeaways
Fig. 25 Germany & Netherlands medical marijuana market: Country outlook, 2019 & 2027
Fig. 26 Germany medical marijuana market estimates and forecasts, 2014 - 2027 (USD Million)
Fig. 27 Netherlands medical marijuana market estimates and forecasts, 2014 - 2027 (USD Million)
Fig. 28 Recent Developments & Impact Analysis, By Key Market Participants
Fig. 29 Company market position analysis, 2019
Fig. 30 Strategic alliance and deals analysis

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[医療用マリファナのドイツ市場2020-2027:製品別(花、油)、用途別(慢性疼痛、精神障害、癌)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆